Postes actifs de Philippe Halfon
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Genoscience Pharma
 Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Directeur/Membre du Conseil | 01/01/2001 | - |
| Fondateur | 01/01/2001 | - | |
| President | 01/01/2001 | - |
Historique de carrière de Philippe Halfon
Statistiques
Internationale
| France | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Founder | 1 |
| President | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Genoscience Pharma
Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Health Technology |
- Bourse
- Insiders
- Philippe Halfon
- Expérience
